Prefibrotic Early Primary Myelofibrosis
📧 Sign up to get email alerts when something new happens for Prefibrotic Early Primary Myelofibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms [Phase 3]
Phase 3 clinical trial AVAJAK compares apixaban or rivaroxaban with aspirin for primary prevention of thromboembolic events in patients with…